dihexa
newDihexa is a synthetic angiotensin IV analogue — a modified dipeptide carrying hexanoic and aminohexanoic groups that increase its metabolic stability. In published preclinical literature it has been investigated for its role in hepatocyte growth factor (HGF/c-Met) signalling and synaptogenesis models. Supplied lyophilized; purity and identity are reported per lot on that lot’s Certificate of Analysis. For laboratory and research use only — not for human or animal consumption. ROEHN makes no claims regarding its effects.
An angiotensin IV analogue studied in SYNAPTOGENESIS research.
This SKU’s current lot has no published certificate yet. No purity, net-content or endotoxin result is shown here until a signed certificate is issued.
Browse published certificates →verified, not promised.
Enter the lot code from your roehn vial to pull its Certificate of Analysis: independent purity and identity results, published exactly as the lab reported them. Lots still in testing say so. Research use only.
Browse certificates →
